Genetic variants in ABO blood group region, plasma soluble E-selectin levels and risk of type 2 diabetes

Human Molecular Genetics

Volumn 19, Issue 9, 2010, Pages 1856-1862

  Qi, Lu ^a,b   Cornelis, Marilyn C ^a   Kraft, Peter ^b   Jensen, Majken ^a   van Dam, Rob M ^a,b   Sun, Qi ^a   Girman, Cynthia J ^c   Laurie, Cathy C ^d   Mirel, Daniel B ^e   Hunter, David J ^a,b   Rimm, Eric ^a,b   Hu, Frank B ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e BROAD INSTITUTE OF MIT AND HARVARD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; AGED; ARTICLE; BLOOD GROUP ABO SYSTEM; CONTROLLED STUDY; FEMALE; GENE CLUSTER; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM;

ABO BLOOD-GROUP SYSTEM; ADULT; DIABETES MELLITUS, TYPE 2; E-SELECTIN; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LINKAGE DISEQUILIBRIUM; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; UNITED STATES;

EID: 77952510546     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddq057     Document Type: Article

References (42)

1. Leeuwenberg, J.F., Smeets, E.F., Neefjes, J.J., Shaffer, M.A., Cinek, T., Jeunhomme, T.M., Ahern, T.J. and Buurman, W.A. (1992) E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro. Immunology, 77, 543-549.
2. Blann, A. and Seigneur, M. (1997) Soluble markers of endothelial cell function. Clin. Hemorheol. Microcirc., 17, 3-11.
3. Meigs, J.B., Hu, F.B., Rifai, N. and Manson, J.E. (2004) Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA, 291, 1978-1986.
4. Song, Y., Manson, J.E., Tinker, L., Rifai, N., Cook, N.R., Hu, F.B., Hotamisligil, G.S., Ridker, P.M., Rodriguez, B.L., Margolis, K.L. et al. (2007) Circulating levels of endothelial adhesion molecules and risk of diabetes in an ethnically diverse cohort of women. Diabetes, 56, 1898-1904.
5. Stranges, S., Rafalson, L.B., Dmochowski, J., Rejman, K., Tracy, R.P., Trevisan, M. and Donahue, R.P. (2008) Additional contribution of emerging risk factors to the prediction of the risk of type 2 diabetes: evidence from the Western New York Study. Obesity (Silver Spring), 16, 1370-1376.
6. Thorand, B., Baumert, J., Chambless, L., Meisinger, C., Kolb, H., Doring, A., Lowel, H. and Koenig, W. (2006) Elevated markers of endothelial dysfunction predict type 2 diabetes mellitus in middle-aged men and women from the general population. Arterioscler. Thromb. Vasc. Biol., 26, 398-405.
7. Malik, I., Danesh, J., Whincup, P., Bhatia, V., Papacosta, O., Walker, M., Lennon, L., Thomson, A. and Haskard, D. (2001) Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis. Lancet, 358, 971-976.
8. Hwang, S.J., Ballantyne, C.M., Sharrett, A.R., Smith, L.C., Davis, C.E., Gotto, A.M. Jr and Boerwinkle, E. (1997) Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation, 96, 4219-4225.
9. Nadar, S., Blann, A.D. and Lip, G.Y. (2004) Endothelial dysfunction: methods of assessment and application to hypertension. Curr. Pharm. Des., 10, 3591-3605.
10. Hara, H., Sugita, E., Sato, R. and Ban, Y. (1996) Plasma selectin levels in patients with Graves' disease. Endocr. J., 43, 709-713.
11. Paterson, A.D., Lopes-Virella, M.F., Waggott, D., Boright, A.P., Hosseini, S.M., Carter, R.E., Shen, E., Mirea, L., Bharaj, B., Sun, L. et al. (2009) Genome-wide association identifies the ABO blood group as a major locus associated with serum levels of soluble E-selectin. Arterioscler. Thromb. Vasc. Biol., 29, 1958-1967.
12. Pare, G., Chasman, D.I., Kellogg, M., Zee, R.Y., Rifai, N., Badola, S., Miletich, J.P. and Ridker, P.M. (2008) Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women. PLoS Genet., 4, e1000118.
13. Melzer, D., Perry, J.R., Hernandez, D., Corsi, A.M., Stevens, K., Rafferty, I., Lauretani, F., Murray, A., Gibbs, J.R., Paolisso, G. et al. (2008) A genome-wide association study identifies protein quantitative trait loci (pQTLs). PLoS Genet., 4, e1000072.
14. Hu, F.B., Meigs, J.B., Li, T.Y., Rifai, N. and Manson, J.E. (2004) Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes, 53, 693-700.
15. Greenwell, P. (1997) Blood group antigens: molecules seeking a function? Glycoconj. J., 14, 159-173.
16. Hosoi, E. (2008) Biological and clinical aspects of ABO blood group system. J. Med. Invest., 55, 174-182.
17. Yamamoto, F., McNeill, P.D. and Hakomori, S. (1992) Human histo-blood group A2 transferase coded by A2 allele, one of the A subtypes, is characterized by a single base deletion in the coding sequence, which results in an additional domain at the carboxyl terminal. Biochem. Biophys. Res. Commun., 187, 366-374.
18. Blann, A.D., Daly, R.J. and Amiral, J. (1996) The influence of age, gender and ABO blood group on soluble endothelial cell markers and adhesion molecules. Br. J. Haematol., 92, 498-500.
19. Kneuer, C., Ehrhardt, C., Radomski, M.W. and Bakowsky, U. (2006) Selectins-potential pharmacological targets? Drug Discov. Today, 11, 1034-1040.
20. Okon, U.A., Antai, A.B., Osim, E.E. and Ita, S.O. (2008) The relative incidence of diabetes mellitus in ABO/Rhesus blood groups in south-eastern Nigeria. Niger. J. Physiol. Sci., 23,1-3.
21. Williams, D.R. and Cartwrigth, R.A. (1979) Genetic polymorphisms in diabetics and non-diabetics. J. Med. Genet., 16, 351-357.
22. Sidhu, L.S., Malhotra, P. and Singh, S.P. (1988) ABO and Rh blood groups in diabetes mellitus. Anthropologischer Anzeiger; Bericht. uber. die. biologisch-anthropologische. Literatur., 46, 269-275.
23. Nemesure, B., Wu, S.Y., Hennis, A. and Leske, M.C. (2006) Hypertension, type 2 diabetes, and blood groups in a population of African ancestry. Ethn. Dis., 16, 822-829.
24. Iyengar, S., Hamman, R.F., Marshall, J.A., Baxter, J., Majumder, P.P. and Ferrell, R.E. (1989) Genetic studies of type 2 (non-insulin-dependent) diabetes mellitus: lack of association with seven genetic markers. Diabetologia, 32, 690-693.
25. O'Donnell, J. and Laffan, M.A. (2001) The relationship between ABO histo-blood group, factor VIII and von Willebrand factor. Transfus. Med., 11, 343-351.
26. Zeggini, E., Scott, L.J., Saxena, R., Voight, B.F., Marchini, J.L., Hu, T., de Bakker, P.I., Abecasis, G.R., Almgren, P., Andersen, G. et al. (2008) Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat. Genet., 40, 638-645.
27. Zeggini, E., Weedon, M.N., Lindgren, C.M., Frayling, T.M., Elliott, K.S., Lango, H., Timpson, N.J., Perry, J.R., Rayner, N.W., Freathy, R.M. et al. (2007) Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science (New York, NY), 316, 1336-1341.
28. Steinthorsdottir, V., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Jonsdottir, T., Walters, G.B., Styrkarsdottir, U., Gretarsdottir, S., Emilsson, V., Ghosh, S. et al. (2007) A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat. Genet., 39, 770-775.
29. Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S. et al. (2007) A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature, 445, 881-885.
30. Scott, L.J., Mohlke, K.L., Bonnycastle, L.L., Willer, C.J., Li, Y., Duren, W.L., Erdos, M.R., Stringham, H.M., Chines, P.S., Jackson, A.U. et al. (2007) A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science (New York, NY), 316, 1341-1345.
31. Colditz, G.A., Manson, J.E. and Hankinson, S.E. (1997) The Nurses' Health Study: 20-year contribution to the understanding of health among women. J. Womens Health, 6, 49-62.
32. Wolpin, B.M., Chan, A.T., Hartge, P., Chanock, S.J., Kraft, P., Hunter, D.J., Giovannucci, E.L. and Fuchs, C.S. (2009) ABO blood group and the risk of pancreatic cancer. J. Nat. Cancer Inst., 101, 424-431.
33. Qi, L., Rifai, N. and Hu, F.B. (2007) Interleukin-6 receptor gene variations, plasma interleukin-6 levels, and type 2 diabetes in U.S. Women. Diabetes, 56, 3075-3081.
34. Pai, J.K., Pischon, T., Ma, J., Manson, J.E., Hankinson, S.E., Joshipura, K., Curhan, G.C., Rifai, N., Cannuscio, C.C., Stampfer, M.J. et al. (2004) Inflammatory markers and the risk of coronary heart disease in men and women. New Engl. J. Med., 351, 2599-2610.
35. Qi, L., van Dam, R.M., Liu, S., Franz, M., Mantzoros, C. and Hu, F.B. (2006) Whole-grain, bran, and cereal fiber intakes and markers of systemic inflammation in diabetic women. Diabetes Care, 29, 207-211.
36. Korn, J.M., Kuruvilla, F.G., McCarroll, S.A., Wysoker, A., Nemesh, J., Cawley, S., Hubbell, E., Veitch, J., Collins, P.J., Darvishi, K. et al. (2008) Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs. Nat. Genet., 40, 1253-1260.
37. Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M.A., Bender, D., Maller, J., Sklar, P., de Bakker, P.I., Daly, M.J. et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet., 81, 559-575.
38. Peiffer, D.A., Le, J.M., Steemers, F.J., Chang, W., Jenniges, T., Garcia, F., Haden, K., Li, J., Shaw, C.A., Belmont, J. et al. (2006) High-resolution genomic profiling of chromosomal aberrations using Infinium whole-genome genotyping. Genome Res., 16, 1136-1148.
39. Price, A.L., Patterson, N.J., Plenge, R.M., Weinblatt, M.E., Shadick, N.A. and Reich, D. (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet., 38, 904-909.
40. Petersen, K.F., Oral, E.A., Dufour, S., Befroy, D., Ariyan, C., Yu, C., Cline, G.W., DePaoli, A.M., Taylor, S.I., Gorden, P. et al. (2002) Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J. Clin. Invest., 109, 1345-1350.
41. Barrett, J.C., Fry, B., Maller, J. and Daly, M.J. (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (Oxford, England), 21, 263-265.
42. Frazer, K.A., Ballinger, D.G., Cox, D.R., Hinds, D.A., Stuve, L.L., Gibbs, R.A., Belmont, J.W., Boudreau, A., Hardenbol, P., Leal, S.M. et al. (2007) A second generation human haplotype map of over 3.1 million SNPs. Nature, 449, 851-861.